- Hastatoside
-
- $35.00 / 1mg
-
2026-01-30
- CAS:50816-24-5
- Min. Order:
- Purity: 99.90%
- Supply Ability: 10g
|
| | 1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα-hydroxy-7α-methyl-5-oxocyclopenta[c]pyran-4-carboxylic acid methyl ester Basic information |
| Product Name: | 1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα-hydroxy-7α-methyl-5-oxocyclopenta[c]pyran-4-carboxylic acid methyl ester | | Synonyms: | 1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα-hydroxy-7α-methyl-5-oxocyclopenta[c]pyran-4-carboxylic acid methyl ester;Hastatoside;Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-4a-hydroxy-7-methyl-5-oxo-, methyl ester, (1S,4aR,7S,7aR)-;methyl (1S,4aR,7S,7aR)-4a-hydroxy-7-methyl-5-oxo-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,6,7,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate;Hastatoside-RM;Hastatoside, 10 mM in DMSO;Methyl (1S,4aR,7S,7aR)-4a-hydroxy-7-methyl-5-oxo-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate | | CAS: | 50816-24-5 | | MF: | C17H24O11 | | MW: | 404.37 | | EINECS: | | | Product Categories: | | | Mol File: | 50816-24-5.mol | ![1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα-hydroxy-7α-methyl-5-oxocyclopenta[c]pyran-4-carboxylic acid methyl ester Structure](CAS/GIF/50816-24-5.gif) |
| | 1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα-hydroxy-7α-methyl-5-oxocyclopenta[c]pyran-4-carboxylic acid methyl ester Chemical Properties |
| Boiling point | 653.5±55.0 °C(Predicted) | | density | 1.58±0.1 g/cm3 (20 ºC 760 Torr) | | storage temp. | -20°C | | pka | 10.20±0.70(Predicted) | | form | Solid | | color | White to off-white | | Major Application | food and beverages | | InChIKey | PRZVXHGUJJPSME-INTLEKPZNA-N | | SMILES | [C@]12(O)C(=O)C[C@H](C)[C@@]1([H])[C@@H](OC=C2C(OC)=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |&1:0,5,7,9,18,20,23,25,27,r| |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | 1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα-hydroxy-7α-methyl-5-oxocyclopenta[c]pyran-4-carboxylic acid methyl ester Usage And Synthesis |
| Chemical Properties | It is a white powder, soluble in organic solvents such as methanol, ethanol, and DMSO. It comes from the whole herb of Verbena officinalis L., a plant of the Verbenaceae family. | | Uses | Hastatoside is an iridoid glucoside isolated found in Verbena officinalis and other herb plants. | | Definition | ChEBI: Hastatoside is an iridoid monoterpenoid with formula C17H24O11 that is isolated from several plants including Verbena officinalis and exhibits a sleep-promoting effect. It has a role as a plant metabolite and a hepatoprotective agent. It is a beta-D-glucoside, an iridoid monoterpenoid, a cyclopentapyran, a monosaccharide derivative, a monoterpene glycoside, an alpha,beta-unsaturated carboxylic ester and a methyl ester. | | in vivo | Hastatoside (0.32-0.64 mmol/kg; oral administration; for 9 hours; male rats of the Sprague-Dawley strain) treatment increases the total time of non-rapid eye movement sleep during a 9-h period, with a lag time of about 3-5 h after the administration at 20. 00 hours (lights-off time). Hastatoside also increases the delta activity during non-rapid eye movement sleep[1]. | Animal Model: | Male rats of the Sprague-Dawley strain (8 weeks old; 260-280 g)[1] | | Dosage: | 0.32 mmol/kg, 0.48 mmol/kg, 0.64 mmol/kg | | Administration: | Oral administration; for 9 hours | | Result: | Increased the total time of non-rapid eye movement sleep during a 9-h period, with a lag time of about 3-5 h after the administration at 20. 00 hours (lights-off time). Also increased the delta activity during non-rapid eye movement sleep.
|
|
| | 1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα-hydroxy-7α-methyl-5-oxocyclopenta[c]pyran-4-carboxylic acid methyl ester Preparation Products And Raw materials |
|